Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 4
1(33.3%)
3Total
N/A(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06713629Not ApplicableCompleted

The Use of PlCO-Vacuum-System on Sternal Wounds

Role: collaborator

NCT06212050Enrolling By Invitation

Feasibility, Safety, and Effectiveness of the ACURATE neo2 Transcatheter Heart Valve for Severe Bicuspid Aortic Stenosis

Role: collaborator

NCT01889966Phase 4Completed

VasoREACTivity Testing With Intravenous SILdenafil in Patients With Precapillary Pulmonary Hypertension

Role: lead

NCT02022878Completed

Computed Tomography Angiography Prediction Score for Percutaneous Revascularization of Chronic Total Occlusions

Role: lead

NCT01811914Not ApplicableCompleted

Focused TTE for Hemodynamic Instable High Risk Patients

Role: collaborator

All 5 trials loaded